CoChat

Characterization of drug binding within the HCN1 channel pore

Open access

The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.

Abstract

Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels mediate rhythmic electrical activity of cardiac pacemaker cells, and in neurons play important roles in setting resting membrane potentials, dendritic integration, neuronal pacemaking, and establishing action potential threshold. Block of HCN channels slows the heart rate and is currently used to treat angina. However, HCN block also provides a promising approach to the treatment of neuronal disorders including epilepsy and neuropathic pain. While several molecules that block HCN channels have been identified, including clonidine and its derivative alinidine, lidocaine, mepivacaine, bupivacaine, ZD7288, ivabradine, zatebradine, and cilobradine, their low affinity and lack of specificity prevents wide-spread use. Different studies suggest that the binding sites of these inhibitors are located in the inner vestibule of HCN channels, but the molecular details of their binding remain unknown. We used computational docking experiments to assess the binding sites and mode of binding of these inhibitors against the recently solved atomic structure of human HCN1 channels, and a homology model of the open pore derived from a closely related CNG channel. We identify a possible hydrophobic groove in the pore cavity that plays an important role in conformationally restricting the location and orientation of drugs bound to the inner vestibule. Our results also help explain the molecular basis of the low-affinity binding of these inhibitors, paving the way for the development of higher affinity molecules.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-018-37116-2

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Docking of HCN blockers to the apo-closed HCN1 pore. The results from 500 attempts to dock clonidine (A) alinidine (B) lidocaine (C) ZD7288 (D) and ivabradine (E) to the closed pore of the cryo-EM structure (PDB: 5U6O). Despite these ligands being known to block or be “trapped” in the closed state, none of the 500 docked poses for any of these inhibitors were observed in the pore cavity. These data indicate that the apo-closed pore conformation must differ from the ligand-trapped closed pore.
Figure 1 Docking of HCN blockers to the apo-closed HCN1 pore. The results from 500 attempts to dock clonidine (A) alinidine (B) lidocaine (C) ZD7288 (D) and ivabradine (E) to the closed pore of the cryo-EM structure (PDB: 5U6O). Despite these ligands being known to block or be “trapped” in the closed state, none of the 500 docked poses for any of these inhibitors were observed in the pore cavity. These data indicate that the apo-closed pore conformation must differ from the ligand-trapped closed pore.CC BY · PubMed Central
Figure 2 Docking of clonidine to the open HCN1 pore. (A) Clustering analysis of the 500 docking attempts. Docks can be placed into 2 clusters according to our automated algorithm. (B) Representative poses from cluster 1 (95% of poses; blue) and cluster 2 (5% of poses; red) are shown. Residues C358 (pink), Y386 (yellow), A387 (purple) and V390 (black) are highlighted. (C) The frequency of residues within 4 Å of the ligand for each pose was assessed and is indicated as a percentage. (D) A comparison of clonidine poses in cluster 1 (blue) and cluster 2 (red). The ligand fits into a hydrophobic groove lined by residues C358, Y386, and A387.
Figure 2 Docking of clonidine to the open HCN1 pore. (A) Clustering analysis of the 500 docking attempts. Docks can be placed into 2 clusters according to our automated algorithm. (B) Representative poses from cluster 1 (95% of poses; blue) and cluster 2 (5% of poses; red) are shown. Residues C358 (pink), Y386 (yellow), A387 (purple) and V390 (black) are highlighted. (C) The frequency of residues within 4 Å of the ligand for each pose was assessed and is indicated as a percentage. (D) A comparison of clonidine poses in cluster 1 (blue) and cluster 2 (red). The ligand fits into a hydrophobic groove lined by residues C358, Y386, and A387.CC BY · PubMed Central
Figure 3 Docking of alinidine to the open HCN1 pore. (A) Clustering analysis of the 500 docking attempts. Docks can be placed into 3 clusters according to our automated algorithm. Cluster 1 (blue), cluster 2 (green) and cluster 3 (red) contained 319, 177 and 4 poses respectively. (B) Top view of the HCN1 pore with representative poses from cluster 1 (blue) and cluster 2 (green) are shown with residues C358 (pink), Y386 (yellow), A387 (purple) and V390 (black) highlighted (C) The frequency of residues within 4 Å of the ligand for each pose was assessed and is indicated as a percentage. (D) A comparison of clonidine poses in cluster 1 (blue) and cluster 2 (green). The ligand fits into a hydrophobic groove lined by residues C358, Y386, and A387.
Figure 3 Docking of alinidine to the open HCN1 pore. (A) Clustering analysis of the 500 docking attempts. Docks can be placed into 3 clusters according to our automated algorithm. Cluster 1 (blue), cluster 2 (green) and cluster 3 (red) contained 319, 177 and 4 poses respectively. (B) Top view of the HCN1 pore with representative poses from cluster 1 (blue) and cluster 2 (green) are shown with residues C358 (pink), Y386 (yellow), A387 (purple) and V390 (black) highlighted (C) The frequency of residues within 4 Å of the ligand for each pose was assessed and is indicated as a percentage. (D) A comparison of clonidine poses in cluster 1 (blue) and cluster 2 (green). The ligand fits into a hydrophobic groove lined by residues C358, Y386, and A387.CC BY · PubMed Central
Figure 4 Docking of lidocaine and derivatives to the open HCN1 pore. (A) Clustering analysis of the 500 docking attempts. Docks can be placed into 5 clusters according to our automated algorithm. (B) Top view of the HCN1 pore with representative poses from cluster 1 (blue) cluster 2 (cyan) and cluster 3 (green) are shown (C) The frequency of residues within 4 Å of the ligand for each pose was assessed and is indicated as a percentage. (D) Side view of representative poses from cluster 1 (blue) cluster 2 (cyan) and cluster 3 (green) are shown. The ligand aromatic ring of lidocaine fits into a hydrophobic groove lined by residues C358, Y386, and A387, while the amine portion of the ligand points toward the central pore axis. (E) Overlay of lidocaine (black) and mepivacaine (blue) docked in the pore of HCN1 channels. Mepivacaine docks with both rings in hydrophobic groove formed by neighbouring subunits, while lidocaine’s amine points toward the pore axis. (F) Mepivacaine (red) and bupivacaine (blue) dock similarly, however, the butyl group on the aromatic ring extends toward the central axis of the pore cavity likely enhancing the occlusion of ions.
Figure 4 Docking of lidocaine and derivatives to the open HCN1 pore. (A) Clustering analysis of the 500 docking attempts. Docks can be placed into 5 clusters according to our automated algorithm. (B) Top view of the HCN1 pore with representative poses from cluster 1 (blue) cluster 2 (cyan) and cluster 3 (green) are shown (C) The frequency of residues within 4 Å of the ligand for each pose was assessed and is indicated as a percentage. (D) Side view of representative poses from cluster 1 (blue) cluster 2 (cyan) and cluster 3 (green) are shown. The ligand aromatic ring of lidocaine fits into a hydrophobic groove lined by residues C358, Y386, and A387, while the amine portion of the ligand points toward the central pore axis. (E) Overlay of lidocaine (black) and mepivacaine (blue) docked in the pore of HCN1 channels. Mepivacaine docks with both rings in hydrophobic groove formed by neighbouring subunits, while lidocaine’s amine points toward the pore axis. (F) Mepivacaine (red) and bupivacaine (blue) dock similarly, however, the butyl group on the aromatic ring extends toward the central axis of the pore cavity likely enhancing the occlusion of ions.CC BY · PubMed Central
Figure 5 Docking of ZD7288 to the open HCN1 pore. (A) Clustering analysis of the 500 docking attempts. Docks can be placed into 24 clusters according to our automated algorithm, indicating that ZD7288 does not bind in a preferred orientation. (B) A representative pose of ZD7288 with residues C358 (pink), Y386 (yellow), A387 (purple) and V390 (black) highlighted. (C) The frequency of residues within 4 Å of the ligand for each pose was assessed and is indicated as a percentage. (D) ZD7288 does not fit nicely into the hydrophobic groove and the aromatic sidechain of Y386 does not appear to contribute to the mechanism of binding as it does for other ligands.
Figure 5 Docking of ZD7288 to the open HCN1 pore. (A) Clustering analysis of the 500 docking attempts. Docks can be placed into 24 clusters according to our automated algorithm, indicating that ZD7288 does not bind in a preferred orientation. (B) A representative pose of ZD7288 with residues C358 (pink), Y386 (yellow), A387 (purple) and V390 (black) highlighted. (C) The frequency of residues within 4 Å of the ligand for each pose was assessed and is indicated as a percentage. (D) ZD7288 does not fit nicely into the hydrophobic groove and the aromatic sidechain of Y386 does not appear to contribute to the mechanism of binding as it does for other ligands.CC BY · PubMed Central
Figure 6 Docking of ivabradine to the open HCN1 pore. (A) Clustering analysis of the 500 docking attempts. Docks cannot be clustered according to our automated algorithm, indicating that ivabradine does not bind in a preferred orientation. (B) Two poses of ivabradine are shown with residues C358 (pink), Y386 (yellow), A387 (purple) and V390 (black) highlighted. Ivabradine in all poses folds into a U-shape, however, is free to rotate 360° in the pore cavity. (C) The frequency of residues within 4 Å of the ligand for each pose was assessed and is indicated as a percentage. (D) None of the ivabradine fit nicely into the hydrophobic groove which is largely prevented by the presence of the methoyx groups on the aromatic ring.
Figure 6 Docking of ivabradine to the open HCN1 pore. (A) Clustering analysis of the 500 docking attempts. Docks cannot be clustered according to our automated algorithm, indicating that ivabradine does not bind in a preferred orientation. (B) Two poses of ivabradine are shown with residues C358 (pink), Y386 (yellow), A387 (purple) and V390 (black) highlighted. Ivabradine in all poses folds into a U-shape, however, is free to rotate 360° in the pore cavity. (C) The frequency of residues within 4 Å of the ligand for each pose was assessed and is indicated as a percentage. (D) None of the ivabradine fit nicely into the hydrophobic groove which is largely prevented by the presence of the methoyx groups on the aromatic ring.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 92 references

Research works printed but not linked: 1

  1. Stockhaus, K. In Problems of Drug Dependence 355-366 (Cambridge: National Academy of Sciences 1977).

Cited by

See all 29

Metadata

Authors
Tanguay, J., Callahan, K. M., & D’Avanzo, N.
Affiliations
Université de Montréal (CA)
Corresponding author
D’Avanzo, Nazzareno
Venue
Scientific Reports
Published
2019-01-24
Volume
9
Issue
1
Pages
465-465
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2911315107
Cited by
29
References
92
Citations by year
2026: 1 · 2025: 1 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 6 · 2020: 4
FWCI
1.41
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Keywords
HCN1 channels, HCN channels, drug binding sites, channel pore, hydrophobic groove, ivabradine, ZD7288, lidocaine, alinidine, binding affinity, molecular docking, pacemaker cells, epilepsy, neuropathic pain
MeSH terms
Ivabradine, Amino Acids, Animals, Binding Sites, Humans, Lidocaine, Ligands, Protein Binding, Structure-Activity Relationship, Drug Discovery, Molecular Dynamics Simulation, Molecular Docking Simulation, Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characterization of drug binding within the HCN1 channel pore. https://app.cochat.ai/papers/10.1038/s41598-018-37116-2
The paper
Tanguay, J., Callahan, K. M., & D’Avanzo, N. (2019). Characterization of drug binding within the HCN1 channel pore. Scientific Reports. https://doi.org/10.1038/s41598-018-37116-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.